Research & KnowledgeEvent: September 1, 2026
Granite Bio resolved IBD risk mapping using cell-type analyses.
Published
Signal category
Research & Knowledge
Quote
“Cell-type resolved IBD risk mapping”
— Dominik Hartl, MD|Granite Bio team
Company
- Industry
- Biotechnology Research
- Location
- Basel, CH
- Company size
- 27 employees
Targeting fundamentals of inflammation, autoimmunity and fibrosis
Founded 2021